Suppr超能文献

衔接蛋白 SH3BGRL 通过促进乳腺癌中 PIK3C3 的翻译和 ATG12 的稳定性来驱动自噬介导的化疗耐药性。

Adaptor SH3BGRL drives autophagy-mediated chemoresistance through promoting PIK3C3 translation and ATG12 stability in breast cancers.

机构信息

Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.

出版信息

Autophagy. 2022 Aug;18(8):1822-1840. doi: 10.1080/15548627.2021.2002108. Epub 2021 Dec 6.

Abstract

Acquired chemotherapy resistance is one of the main culprits in the relapse of breast cancer. But the underlying mechanism of chemotherapy resistance remains elusive. Here, we demonstrate that a small adaptor protein, SH3BGRL, is not only elevated in the majority of breast cancer patients but also has relevance with the relapse and poor prognosis of breast cancer patients. Functionally, SH3BGRL upregulation enhances the chemoresistance of breast cancer cells to the first-line doxorubicin treatment through macroautophagic/autophagic protection. Mechanistically, SH3BGRL can unexpectedly bind to ribosomal subunits to enhance PIK3C3 translation efficiency and sustain ATG12 stability. Therefore, inhibition of autophagy or silence of PIK3C3 or ATG12 can effectively block the driving effect of SH3BGRL on doxorubicin resistance of breast cancer cells in vitro and in vivo. We also validate that SH3BGRL expression is positively correlated with that of PIK3C3 or ATG12, as well as the constitutive occurrence of autophagy in clinical breast cancer tissues. Taken together, our data reveal that SH3BGRL upregulation would be a key driver to the acquired chemotherapy resistance through autophagy enhancement in breast cancer while targeting SH3BGRL could be a potential therapeutic strategy against breast cancer. ABCs: ATP-binding cassette transporters; Act D: actinomycin D; ACTB/β-actin: actin beta; ATG: autophagy-related; Baf A: bafilomycin A; CASP3: caspase 3; CHX: cycloheximide; CQ: chloroquine; Dox: doxorubicin; FBS: fetal bovine serum; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GEO: gene expression omnibus; GFP: green fluorescent protein; G6PD: glucose-6-phosphate dehydrogenase; GSEA: gene set enrichment analysis; IHC: immunochemistry; KEGG: Kyoto Encyclopedia of Genes and Genomes; MAP1LC3B/LC3B: microtubule-associated protein 1 light chain 3 beta; 3-MA: 3-methyladenine; mRNA: messenger RNA; PIK3C3: phosphatidylinositol 3-kinase catalytic subunit type 3; SH3BGRL: SH3 domain binding glutamate-rich protein-like; SQSTM1/p62: sequestosome 1; ULK1: unc-51 like autophagy activating kinase 1.

摘要

获得性化疗耐药性是乳腺癌复发的主要罪魁祸首之一。但化疗耐药性的潜在机制仍难以捉摸。在这里,我们证明了一种小衔接蛋白 SH3BGRL 不仅在大多数乳腺癌患者中升高,而且与乳腺癌患者的复发和预后不良有关。功能上,SH3BGRL 的上调通过巨自噬/自噬保护增强了乳腺癌细胞对一线阿霉素治疗的耐药性。在机制上,SH3BGRL 可以意外地与核糖体亚基结合,以提高 PIK3C3 的翻译效率并维持 ATG12 的稳定性。因此,抑制自噬或沉默 PIK3C3 或 ATG12 可以有效地阻断 SH3BGRL 在体外和体内对乳腺癌细胞阿霉素耐药性的驱动作用。我们还验证了 SH3BGRL 的表达与 PIK3C3 或 ATG12 的表达以及临床乳腺癌组织中自发发生的自噬呈正相关。总之,我们的数据表明,SH3BGRL 的上调通过增强自噬成为乳腺癌获得性化疗耐药的关键驱动因素,而靶向 SH3BGRL 可能是一种针对乳腺癌的潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b9/9450985/4829543de3e5/KAUP_A_2002108_F0001_C.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验